GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Japan Tissue Engineering Co 7774.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

634

+8.19%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥2.18bn

FY2017FY2026

Net income

−¥734.8m

FY2017FY2026

Free cash flow

−¥562.7m

FY2017FY2026

Shareholders' equity

¥5.09bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥2.18bn¥2.46bn¥2.51bn¥2.03bn¥2.10bn¥2.26bn¥2.31bn¥2.36bn¥2.27bn¥2.14bn
Gross profit¥1.23bn¥1.47bn¥1.67bn¥1.12bn¥1.24bn¥1.14bn¥1.15bn¥1.24bn¥1.29bn¥1.19bn
Research and development¥497.3m¥506.7m¥407.0m¥573.3m¥561.9m¥468.9m¥321.7m¥588.4m¥183.8m¥20.7m
Operating income−¥549.4m−¥238.3m¥144.5m−¥728.1m−¥498.2m−¥466.9m−¥235.2m−¥348.5m¥206.6m¥307.5m
Net income−¥734.8m−¥255.3m¥143.2m−¥729.3m−¥497.9m−¥466.6m−¥287.1m−¥333.2m¥227.9m¥276.2m
Diluted earnings per share-18.09-6.293.53-17.96-12.26-11.49-7.07-8.215.616.80

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥5.68bn¥6.51bn¥6.99bn¥6.88bn¥7.60bn¥8.12bn¥8.45bn¥8.75bn¥9.02bn¥8.55bn
Cash and short-term investments¥3.25bn¥3.89bn¥4.27bn¥4.13bn¥4.93bn¥5.28bn¥5.75bn¥5.93bn¥6.20bn¥4.09bn
Total liabilities¥592.7m¥688.0m¥908.4m¥946.1m¥931.7m¥954.8m¥820.5m¥833.8m¥771.6m¥541.2m
Debt——¥35.4m¥133,000¥936,000¥1.7m¥3.0m¥6.2m¥8.1m¥14.6m
Shareholders' equity¥5.09bn¥5.83bn¥6.08bn¥5.94bn¥6.67bn¥7.16bn¥7.63bn¥7.92bn¥8.25bn¥8.01bn
Shares outstanding41m41m41m41m41m41m41m41m41m41m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥488.0m−¥148.4m¥274.1m−¥622.6m−¥225.2m−¥399.6m−¥84.6m−¥396.1m¥632.0m¥55.0m
Capital spending−¥74.6m−¥76.1m−¥195.9m−¥149.1m−¥102.6m−¥62.2m−¥86.5m−¥68.9m−¥31.2m−¥8.0m
Free cash flow−¥562.7m−¥224.5m¥78.2m−¥771.7m−¥327.8m−¥461.8m−¥171.1m−¥465.0m¥600.8m¥46.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥766.8m¥673.1m¥510.9m¥572.3m¥426.4m¥749.1m¥544.6m¥719.5m
Gross profit¥512.5m¥432.0m¥292.7m¥326.2m¥216.4m¥511.2m¥328.4m¥424.5m
Operating income¥59.1m¥13.9m−¥187.1m−¥131.7m−¥244.5m¥93.5m−¥124.5m−¥14.1m
Net income¥52.2m−¥178.6m−¥184.8m−¥129.0m−¥242.4m¥94.7m−¥124.7m−¥14.2m
Diluted earnings per share1.29-4.40-4.55-3.18-5.972.33-3.07-0.35
Total assets¥5.91bn¥5.68bn¥5.89bn¥6.10bn¥6.29bn¥6.51bn¥6.45bn¥6.49bn
Cash and short-term investments¥3.35bn¥3.25bn¥3.34bn¥3.73bn¥3.92bn¥3.89bn¥4.07bn¥4.04bn
Shareholders' equity¥5.14bn¥5.09bn¥5.27bn¥5.45bn¥5.58bn¥5.83bn¥5.73bn¥5.86bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.4%-0.7%4.3%
Operating income-9.0%3.3%-5.4%
Net income0.2%9.5%0.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin58.1%59.6%58.0%55.1%
Operating margin-17.0%-14.9%-17.2%-14.0%
Net margin-21.3%-17.2%-18.8%-13.9%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-33.3-98.9131.3-28.2-38.1-49.3-87.1-118.2138.8180.2
Price to sales11.210.37.510.19.010.210.816.713.923.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 200-for-1 split · 27 Mar 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.